LAPTM5 and cancer: Here, we report that expression of LAPTM5 is frequently decreased at the transcriptional level in various types of human cancer cell lines and in non-small cell lung cancer (NSCLC) and esophageal squamous cell carcinoma (ESCC) tumors, and low expression is associated with poor prognosis of patients with such tumors.